Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

45.80 +4.70 (+11.42%)
Streaming Delayed Price Updated: 11:17 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna Inc

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
Invest in stability, dividends, and growth with these three accomplished real estate operators. 
Via The Motley Fool
Better Cathie Wood Stock: Moderna vs. Intellia
Moderna and Intellia have declined in the double digits over the past year. 
Via The Motley Fool
3 Biotech Stocks to Buy on the Dip: March 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three. 
Via InvestorPlace
What's Going On With Moderna Stock Wednesday?
Moderna shares are trading higher Wednesday after the company announced that MRNA-1283 met the primary endpoints in its Phase 3 clinical trial. Additionally, Blackstone Life Sciences announced an... 
Via Benzinga
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Via ACCESSWIRE
Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today
Via Benzinga
Behind the Scenes of Moderna's Latest Options Trends
Via Benzinga
Peering Into Moderna's Recent Short Interest
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $5,000 Today
Via Benzinga
Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
Via Benzinga
Moderna's Next Gen COVID Vaccine Meets Primary Goal In Late-Stage Trial
Moderna announces Phase 3 trial results for mRNA-1283, its next-gen COVID-19 vaccine. A higher immune response was observed compared to mRNA-1273.222. Detailed data will be unveiled at upcoming... 
Via Benzinga
Exposures COVID-19
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Via ACCESSWIRE
Cathie Wood's Ark Ups Tesla Bet With $28M Stock Buy Amid Rebound, Also Loads Up On This Online Game Platform
Through its two ETFs, Ark Innovation ETF and ARK Next Generation Internet ETF, Ark bought 163,421 Tesla shares. 
Via Benzinga
Topics ETFs
Two Hot AI Stocks Lead S&P 500 Monday
Super Micro and Micron , two big winners in 2024, led the way Monday. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Moderna Stock: Bull vs. Bear
This stock delivered spectacular gains in the past. 
Via The Motley Fool
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
These stocks share several things in common. 
Via The Motley Fool
Artificial Intelligence (AI) in Healthcare: 2 Top Stock Picks
These particular healthcare stocks are dirt cheap now considering their AI potential. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts
Ark, through its flagship Ark Innovation ETF and Ark Genomic Revolution ETF, has been brisk with its acquisition of Moderna shares in March. 
Via Benzinga
Topics ETFs
Exposures COVID-19
Cathie Wood's Ark Invest Sells Another Tranche Of Block Shares, Even As Bitcoin Price Stages A Recovery
On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CRYPTO: BTC) prices recovering. 
Via Benzinga
Why Moderna Shares Are Falling
Moderna shares are trading lower by 2.7% during Wednesday's session. The stock is falling in possible sympathy with BioNTech, which reported worse than expected fourth-quarter earnings. 
Via Benzinga
BioNTech Tumbles As Fourth-Quarter Sales Dive 65% And Miss Forecasts
BioNTech also reported plummeting earnings that missed forecasts and issued light 2024 guidance. 
Via Investor's Business Daily
Cathie Wood's Ark Invest Isn't Done Selling Shares Of Jack Dorsey-Led Block Yet — Sheds $7.5M Worth of Stock As Bitcoin Price Drops
On Tuesday, Cathie Wood-led Ark Invest offloaded a significant amount of Block Inc (NYSE:SQ) shares amidst a downturn in Bitcoin (CRYPTO: BTC) prices. 
Via Benzinga
Cathie Wood-Led Ark Invest Sheds Shares Of Jack Dorsey's Block And Coinbase As Bitcoin, Ethereum Take A Breather
On Monday, Cathie Wood-led Ark Invest made significant trades, notably offloading shares of Coinbase Global Inc (NASDAQ:COIN) and Block Inc (NYSE:SQ), despite 
Via Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week
Wood doesn't worry about short-term share price performance. She bets on the long term. 
Via The Motley Fool
3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise
Dive into the potential of precision medicine stocks poised to revolutionize healthcare and offer substantial growth opportunities. 
Via InvestorPlace
Reviving Interest: Moderna
Here’s a stock I haven’t thought about in a long time: Covid-mega-beneficiary Moderna​, which seems to have a rock-solid price sealing at about $118. 
Via Talk Markets
Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz
On Tuesday, Cathie Wood-led Ark Invest made a significant move by offloading a substantial number of shares in Coinbase Global Inc (NASDAQ:COIN), despite Bitcoin (CRYPTO: BTC) reaching new 
Via Benzinga
Natural Gas Prices Are Falling Again. Chinese Indices Are Growing Amid Support From The Central Bank
The Dow Jones Index (US30) was up 0.12% at Monday's stock market close. The S&P 500 Index (US500) was down 0.11%. The NASDAQ Technology Index (US100) closed negative 0.41%. 
Via Talk Markets
Topics Economy Energy Stocks
Exposures Fossil Fuels Interest Rates US Equities
Moderna Nears Its First Breakout In Over A Year After Launching Third Cancer Vaccine Test
Moderna and Merck are now testing their cancer vaccine in patients with another form of skin cancer. 
Via Investor's Business Daily
What's Going On With Moderna Stock On Monday?
Merck's trial with Moderna's V940 for advanced cutaneous squamous cell carcinoma. The neoadjuvant and adjuvant therapy with pembrolizumab, aiming for superior event-free survival. Phase 3 expansion... 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.